Index by author

April 2014; Volume 34,Issue 4

Special Issue on New Anticancer Agents

  1. Aaron, JOANN

    1. Pediatric Patients with Refractory Central Nervous System Tumors: Experiences of a Clinical Trial Combining Bevacizumab and Temsirolimus
      SARINA A. PIHA-PAUL, SANG JOON SHIN, TRIBHAWAN VATS, NANDITA GUHA-THAKURTA, JOANN AARON, MICHAEL RYTTING, EUGENIE KLEINERMAN and RAZELLE KURZROCK
      Anticancer Research April 2014, 34 (4) 1939-1945;

  2. Abdelhamed, SHERIF

    1. Piperine Enhances the Efficacy of TRAIL-based Therapy for Triple-negative Breast Cancer Cells
      SHERIF ABDELHAMED, SATORU YOKOYAMA, ALAA REFAAT, KEISUKE OGURA, HIDEO YAGITA, SURESH AWALE and IKUO SAIKI
      Anticancer Research April 2014, 34 (4) 1893-1899;

  3. Abdissa, TEMESGEN T.

    1. Bosutinib Reduces the Efficacy of Dasatinib in Triple-negative Breast Cancer Cell Lines
      MIKE TARPLEY, TEMESGEN T. ABDISSA, GARY L. JOHNSON and JOHN E. SCOTT
      Anticancer Research April 2014, 34 (4) 1629-1635;

  4. Abe, TOSHI

    1. Multimodal Approach for Cervical Esophageal Carcinoma: Role of Neoadjuvant Chemotherapy
      GEN SUZUKI, HIDEYA YAMAZAKI, ETSUYO OGO, TOSHI ABE, HIDEHIRO ETO, KOICHIRO MURAKI, CHIKAYUKI HATTORI, HIROHITO UMENO, TADASHI NAKASHIMA, TOSHIAKI TANAKA, SATOAKI NAKAMURA and KEN YOSHIDA
      Anticancer Research April 2014, 34 (4) 1989-1992;

  5. Abiko, YOSHIMITSU

    1. Sodium Butyrate, a Histone Deacetylase Inhibitor, Regulates Lymphangiogenic Factors in Oral Cancer Cell Line HSC-3
      TAKASHI YAMAMURA, NAOYUKI MATSUMOTO, YASUYOSHI MATSUE, MICHISATO OKUDERA, YOUICHI NISHIKAWA, YOSHIMITSU ABIKO and KAZUO KOMIYAMA
      Anticancer Research April 2014, 34 (4) 1701-1708;

  6. Abu, RYOGO

    1. Inhibitory Effect of Orally-administered Sulfated Polysaccharide Ascophyllan Isolated from Ascophyllum nodosum on the Growth of Sarcoma-180 Solid Tumor in Mice
      ZEDONG JIANG, RYOGO ABU, SHOGO ISAKA, SATORU NAKAZONO, MIKINORI UENO, TAKASI OKIMURA, KENICHI YAMAGUCHI and TATSUYA ODA
      Anticancer Research April 2014, 34 (4) 1663-1671;

  7. Abuzenadah, ADEL M.

    1. Impact of S100A8 Expression on Kidney Cancer Progression and Molecular Docking Studies for Kidney Cancer Therapeutics
      ZEENAT MIRZA, HANS-JUERGEN SCHULTEN, HASAN MA FARSI, JAUDAH A. AL-MAGHRABI, MAMDOOH A. GARI, ADEEL GA CHAUDHARY, ADEL M. ABUZENADAH, MOHAMMED H. AL-QAHTANI and SAJJAD KARIM
      Anticancer Research April 2014, 34 (4) 1873-1884;

  8. Achel, DANIEL GYINGIRI

    1. Radiosensitizing Effect of Rosmarinic Acid in Metastatic Melanoma B16F10 Cells
      MIGUEL ALCARAZ, MIGUEL ALCARAZ-SAURA, DANIEL GYINGIRI ACHEL, AMPARO OLIVARES, JOSÉ ANTONIO LÓPEZ-MORATA and JULIÁN CASTILLO
      Anticancer Research April 2014, 34 (4) 1913-1921;

  9. Akashi, KOICHI

    1. Analysis of Adverse Events of Bevacizumab-containing Systemic Chemotherapy for Metastatic Colorectal Cancer in Japan
      TAICHI ISOBE, KEITA UCHINO, CHINATSU MAKIYAMA, HIROSHI ARIYAMA, SHUJI ARITA, SHINGO TAMURA, MASATO KOMODA, HITOSHI KUSABA, TSUYOSHI SHIRAKAWA, TAITO ESAKI, KENJI MITSUGI, SHIGEO TAKAISHI, KOICHI AKASHI and EISHI BABA
      Anticancer Research April 2014, 34 (4) 2035-2040;

  10. Akira, MASANORI

    1. A Pilot Study of Cisplatin and Etoposide With and Without Radiotherapy for Advanced Malignant Thymoma
      AKIHIRO TAMIYA, AKIHIDE MATSUMURA, TAISUKE TSUJI, MASAHIRO MORIMOTO, KAZUHIRO ASAMI, KYOICHI OKISHIO, SHIGEKI SHIMIZU, HYUNG-EUN YOON, SHINJI ATAGI, MASANORI AKIRA, MASANORI KITAICHI and TOMOYA KAWAGUCHI
      Anticancer Research April 2014, 34 (4) 2023-2027;
« Previous (Pages : 1 2 3 4 5 6 ... 47) Next »
Back to top

In this issue